Health Media Articles

Excerpts of Key Health Media Articles in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Residues of many types of insecticides, fungicides and weed killing chemicals have been found in roughly 85 percent of thousands of foods tested. Data released ... by the U.S. Department of Agriculture shows varying levels of pesticide residues in everything from mushrooms to potatoes and grapes to green beans. One sample of strawberries contained residues of 20 pesticides. Notably, the agency said only 15 percent of the 10,187 samples tested were free from any detectable pesticide residues. That’s a marked difference from 2014, when the USDA found that over 41 percent of samples were “clean” or showed no detectable pesticide residues. Prior years also showed roughly 40-50 percent of samples as free of detectable residues. Absent from the USDA data was any information on glyphosate residues, even though glyphosate has long been the most widely used herbicide in the world. The Food and Drug Administration also annually samples foods for residues of pesticides. The most recent public residue report issued by the FDA shows that violation rates for pesticide residues have been climbing in recent years.

Note: For more, see this mercola.com article. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

After 30 years of immunology research, [Louis Picker] is on the verge of launching human trials for a vaccine that could stop AIDS, an epidemic that has become something of an afterthought decades after it began ravaging gay men in America. For many in the developed world, complacency has set in, largely thanks to a regimen of antiretroviral drugs that allow people with HIV to live long and healthy lives, and decades of failed attempts to develop a vaccine. In 1984, U.S. Secretary of Health and Human Services Margaret Heckler expressed hope ... that science might have a vaccine for HIV within two years. Instead, a decade passed, and by 1994, AIDS was the leading cause of death for Americans ages 25 to 44. Four vaccines have made it to human trials, but none made it to market. As Picker continued his research, scientists developed a series of antiretroviral drugs that slowly downgraded HIV to a chronic disease ... in the developed world. But globally, AIDS is still killing a lot of people, largely because most of those infected in poorer countries don't have access to the drugs. According to the World Health Organization, 1.1 million people died from AIDS in 2015. In the U.S., 50,000 new cases of HIV are reported every year. Worldwide, the number is 2 million. Every time news reports come out about Picker's research, he fields a series of phone calls from HIV-infected patients, their friends and their family. "Can I be in your trial?" people ask him. "Please, can you save my son?"

Note: How is it that COVID-19 vaccines were created just months after it became a threat while many decades later no vaccine has been found for the deadly AIDS epidemic, which according to the WHO has killed 36 million - many times the number of deaths from COVID? For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

A breathing-based meditation practice known as Sudarshan Kriya yoga helped alleviate severe depression in people who did not fully respond to antidepressant treatments, reports a new study published in the Journal of Clinical Psychiatry. Researchers found significant improvement in symptoms of depression and anxiety in medicated patients with major depressive disorder (MDD) who participated in the breathing technique compared to medicated patients who did not partake. More than half of the 41 million Americans who take antidepressants do not fully respond. Add-on therapies are often prescribed to enhance the effects of the drugs in these patients, but they typically offer limited additional benefits and come with side effects that can [prolong] the depressive episode. The meditation technique ... includes a series of sequential, rhythm-specific breathing exercises that bring people into a deep, restful, and meditative state: slow and calm breaths alternated with fast and stimulating breaths. In past studies, the practice has demonstrated a positive response in patients with milder forms of depression, depression due to alcohol dependence, and in patients with MDD; however, there are no clinical studies investigating its use for depression in an outpatient setting. Past studies suggest that yoga and other controlled breathing techniques can potentially adjust the nervous system to reduce stress hormones.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

On its website, Kellogg touted a distinguished-sounding "Breakfast Council" of "independent experts" who helped guide its nutritional efforts. Nowhere did it say this: The maker of Froot Loops and Frosted Flakes paid the experts and fed them talking points. The company paid the experts an average of $13,000 a year, prohibited them from offering media services for products "competitive or negative to cereal" and required them to engage in "nutrition influencer outreach" on social media or with colleagues, and report back on their efforts. For Kellogg, the breakfast council - in existence between 2011 and this year - deftly blurred the lines between cereal promotion and impartial nutrition guidance. The company used the council to teach a continuing education class for dietitians, publish an academic paper on breakfast, and try to influence the government's dietary guidelines. One of the breakfast council's most notable achievements was publishing a paper defining a "quality breakfast" in a nutrition journal. Kellogg touted the paper in its newsletter as being written by "our independent nutrition experts." Dietitians could earn continuing education credits from the publisher for taking a quiz about the paper. Kellogg didn't describe its own role in overseeing editing and providing feedback, such as asking for the removal of a line saying a recommendation that added sugar be limited to 25 percent of calories might be "too high."

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in science and in the food system.

Seth Ellingsworth of West Richland, Washington, says he got sick in an instant last year, when he briefly inhaled a strange odor at his job at the nearby Hanford Nuclear Site. Seventy years ago, the Hanford Site produced plutonium for America's nuclear arsenal. Today, it's run by the Department of Energy through its contractor, Washington River Protection Solutions. The contractor is managing a $110 billion cleanup of 56 million gallons of chemical and nuclear waste, stored in 177 underground tanks. But the tanks are leaking, and the vapors they emit contain toxic and radioactive chemicals. Some nuclear experts have called Hanford "the most toxic place in America" and "an underground Chernobyl waiting to happen." The DOE has acknowledged in nearly 20 studies conducted over the past 24 years that there is a safety risk to workers at Hanford. But critics say the DOE ... continues to put workers at risk. Neuropsychologist Brian Campbell says he has evaluated 29 people at Hanford with both respiratory and cognitive symptoms, including "some of the worst cases of dementia that I've seen in young people." Dr. Campbell said the DOE doesn't want to acknowledge the injuries. Workers told us that "over and over," the Department of Energy and the contractor on site told them the readings for harmful materials were safe. Former workers also said that in the past they were almost never allowed to opt for protective gear, like the supplied air tanks recommended by many experts.

Note: A Newsweek article describes the Hanford site as an "American Fukushima" that will require 50 more years and $110 billion to adequately clean up. For more along these lines, see concise summaries of deeply revealing nuclear power news articles from reliable major media sources.

In every state, patient protection is supposed to be the prime directive when it comes to licensing and disciplining doctors. But a 50-state examination by The Atlanta Journal-Constitution found that only a few states have anything close to a comprehensive set of laws that put patients first. “Instead of looking out for victims or possible victims or protecting our society, we’re protecting doctors,” said Rep. Kimberly Williams, a member of the Delaware General Assembly, who sponsored a patient-protection bill last year that was blocked with a veto. The AJC studied five categories of laws in every state in the nation to determine which states are the best - and the worst - at shielding patients from sexually abusive doctors. The statutes examined covered everything from the duty to report bad doctors and the power to revoke the licenses of the worst, to the laws that decide who gets to serve on medical licensing boards and how much information consumers can know about doctors who have gotten into trouble. Not a single state met the highest bar in every category. The AJC’s findings explain how it’s possible for a doctor who has served time on felony charges, molested patients or demanded sex in exchange for prescription drugs to continue seeing patients: In most states, there’s no law against it. It often takes a horrific case or a public expose to get pro-patient legislation passed.

Note: See a list of powerful articles revealing egregious and rampant sexual abuse by doctors around the US. For more along these lines, see concise summaries of deeply revealing news articles on sexual abuse scandals and health.

Government testing for residues of an herbicide that has been linked to cancer has been put on hold, slowing the Food and Drug Administration’s first-ever endeavor to get a handle on just how much of the controversial chemical is making its way into U.S. foods. The FDA ... launched what it calls a “special assignment” earlier this year to analyze certain foods for residues of the weed killer called glyphosate after the agency was criticized by the U.S. Government Accountability Office for failing to include glyphosate in annual testing programs that look for many less-used pesticides. Glyphosate is the most widely used herbicide in the world, and is the key ingredient in Monsanto Co.’s branded Roundup herbicide line. Several private groups ... have been finding glyphosate residues in varying levels in a range of foods. Earlier this year, one of the agency’s senior chemists also analyzed glyphosate residues in honey and oatmeal and [found that some] samples contained residue levels well over the limit allowed in the European Union. The agency ... put the glyphosate residue testing part of the work plan on hold amid confusion, disagreement and difficulties with establishing a standard methodology to use across the agency’s multiple U.S. laboratories, according to FDA sources. With the testing on hold, it is not clear when the agency might have final results on the glyphosate residue analysis.

Note: Laboratory tests have shown alarming levels of glyphosate in many common foods. For more along these lines, see concise summaries of deeply revealing news articles on government corruption and health.

Essential medicines could be provided for as little as $1-$2 US a month per person in developing countries, experts said on Monday as they called on governments to boost efforts to ensure everyone can access basic healthcare. Although global spending on medicines is about eight times this amount, one in five countries spends less than $1 per month per person, according to the first analysis of the cost of providing key drugs by The Lancet Commission on Essential Medicines. The commission, comprising 21 international experts, said lack of access to affordable, quality medicines was threatening progress towards universal health coverage. The list of essential medicines contains 201 drugs needed for a basic healthcare system. The commission estimated the cost of providing essential medicines to the populations of low- and middle-income countries to be between $77 billion and $152 billion a year. It said 41 countries were spending less than $1 per person per month on medicines while global spending on medicines in 2017 was predicted to be $1.2 trillion. The experts said "massive inequities and inefficiencies" in financing and governance were restricting access to drugs for many people. They said persistent problems with the quality and safety of medicines in many low- and middle-income countries must also be addressed with better regulation, [and] called for urgent reforms in the way essential drugs are developed and patented to improve affordability and access.

Note: For more along these lines, see concise summaries of deeply revealing news articles on income inequality and health.

The Washington, D.C.-based Grocery Manufacturers Association (GMA) has been slapped with a $6 million civil penalty, which will be trebled due to its "intentional violations of state law" for laundering money in a 2013 Washington state initiative campaign. If the ... $18 million in total damages holds up on appeal, it may be the highest fine for campaign finance violations in the history of the United States. The grocery lobby group poured more than $11 million into the "No on 522" committee, which fought and narrowly defeated an initiative to require labeling of genetically modified foods and seeds sold to consumers in the state. What prompted the massive award? The GMA established what it called a "defense of brands account." It collected money to defeat the Washington initiative while shielding the identities of major food manufacturers (e.g. Pepsico, Coca-Cola, General Mills, General Foods) who were putting up millions of dollars in support. The GMA, its members and other sources had spent $43 million in 2012 to defeat California's Proposition 37, which would have required all packaged food products to identify genetically modified organisms. "While successfully defeating Prop. 37, certain individual member companies of GMA and some GMA staff received negative responses from the public because of their opposition to Prop. 37," Judge Hirsch wrote in her ruling. Hence, an elaborate scheme was hatched - and approved by the GMA's board - to conceal individual donors.

Note: Read a more in-depth, revealing article on this on mercola.com. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and the GMO controversy.

Testing for residues of an herbicide developed by Monsanto Co. that has been linked to cancer has turned up high levels in honey from the key farm state of Iowa, adding to concerns about contamination. The Food and Drug Administration began glyphosate residue testing in a small number of foods earlier this year after the International Agency for Research on Cancer classified glyphosate as a probable human carcinogen. Research by FDA chemist Narong Chamkasem and John Vargo, a chemist at the University of Iowa, shows that residues of glyphosate - the chief ingredient in Monsanto’s branded Roundup herbicide - have been detected [in honey] at ... more than 10 times the limit of 50 ppb allowed in the European Union. “According to recent reports, there has been a dramatic increase in the usage of these herbicides, which are of risk to both human health and the environment,” Chamkasem and Vargo stated in their laboratory bulletin. Because there is no legal tolerance level for glyphosate in honey in the United States, any amount could technically be considered a violation, according to statements made in FDA internal emails, obtained through Freedom of Information Act (FOIA) requests. The Environmental Protection Agency may soon move to set a tolerance, however. The agency has set tolerance levels for glyphosate residues in many foods the EPA expects might contain residues of the weed killer.

Note: For more, read this mercola.com article. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

A former top Drug Enforcement Administration (DEA) official has accused Congress of putting pharmaceutical company profits ahead of public health in the battle to combat the US’s prescription opioid epidemic. Joseph Rannazzisi, head of the DEA office responsible for preventing prescription medicine abuse until last year, said drug companies and their lobbyists have a “stranglehold” on Congress to protect a $9bn a year trade in opioid painkillers claiming the lives of nearly 19,000 people a year. Rannazzisi ... said the drug industry engineered recent legislation limiting the DEA’s powers to act against pharmacies endangering lives by dispensing disproportionately large numbers of opioids. He also accused lobbyists ... of whipping up opposition to new guidelines for doctors intended to reduce the prescribing of the painkillers. Charges that Congress is too beholden to pharmaceutical companies have been levelled for years. But ... the influence on opioid policies is particularly disturbing because so many lives are being lost. Industry groups have spent hundreds of millions of dollars in lobbying to stave off measures to reduce prescriptions and therefore sales of opioid painkillers. Among the most influential drug industry groups is the Pain Care Forum, co-founded by a top executive of Purdue Pharma – the manufacturer of the opioid which unleashed the addiction epidemic, OxyContin. It spent $740m lobbying Congress and state legislatures over the past decade.

Note: See also a Washington Post article for more. For more, see concise summaries of deeply revealing news articles on government corruption and Big Pharma profiteering.

Genetic modification in the United States and Canada has not accelerated increases in crop yields or led to an overall reduction in the use of chemical pesticides. The promise of genetic modification was twofold: By making crops immune to the effects of weedkillers and inherently resistant to many pests, they would grow so robustly that they would become indispensable to feeding the worlds growing population, while also requiring fewer applications of sprayed pesticides. Twenty years ago, Europe largely rejected genetic modification at the same time the United States and Canada were embracing it. Comparing results on the two continents ... shows how the technology has fallen short of the promise. The United States and Canada have gained no discernible advantage in yields - food per acre - when measured against Western Europe. Also, a recent National Academy of Sciences report found that there was little evidence that the introduction of genetically modified crops in the United States had led to yield gains beyond those seen in conventional crops. At the same time, herbicide use has increased in the United States. And the United States has fallen behind Europes biggest producer, France, in reducing the overall use of pesticides, which includes both herbicides and insecticides. Pesticides are toxic by design ... and have been linked to developmental delays and cancer. The same companies make and sell both the genetically modified plants and the poisons.

Note: Explore over 40 scientific studies that have demonstrated the health dangers of GM foods. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and the GMO controversy.

Sugar pills worked as well at preventing kids' migraines as two commonly used headache medicines, but had fewer side effects, in a study that may lead doctors to rethink how they treat a common ailment in children and teens. It's the first rigorous head-to-head test in kids of two generic prescription drugs also used for adults' migraines: topiramate, an anti-seizure medicine, and amitriptyline, an anti-depressant. The idea was to see if either drug could reduce by half the number of days kids had migraines over a month's time. Both drugs worked that well - but so did placebo sugar pills. The results "really challenge what is typical practice today by headache specialists," said study author Scott Powers, a psychologist at Cincinnati Children's Hospital. "The fact that it shows that two of the most commonly used medications are no more effective than a placebo and have adverse effects makes a very clear statement," said Dr. Leon Epstein, neurology chief at Ann & Robert Lurie H. Children's Hospital of Chicago. The only government-approved migraine medication for kids is topiramate. Side effects from the drugs [included] fatigue, dry mouth and forgetfulness. Kids on topiramate also had tingling sensations in their hands, arms, legs or feet. There was one suicide attempt in the topiramate group, another known side-effect of that drug. The side effects were not unexpected, but given the risks, the results suggest the drugs shouldn't be "first-line prevention treatments" for kids' migraines, Powers said.

Note: This study was published in the New England Journal of Medicine. For more, see this mercola.com article. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

HIV likely landed in the United States a full decade before the first AIDS reports made headlines, according to a report released Wednesday that also strongly dismisses the long-held myth that a single man, a flight attendant notoriously known as “Patient Zero,” was responsible for the domestic epidemic. The report, published Wednesday in the journal Nature, traces the lineage of HIV from Africa to Haiti to New York and, finally, San Francisco. The virus seems to have arrived in New York around 1971, and in San Francisco five years later. By the time doctors were reporting the first AIDS cases in 1981, the virus would have been deeply embedded in cities all over the country. The fact that HIV predated those first AIDS reports - and that the so-called Patient Zero could not have been responsible for the epidemic - has long been known by AIDS researchers. But the new paper ... provides perhaps the most detailed genetic history of the virus’ geographic movement. The new study, when coupled with previous work, gives a fairly clear picture of HIV’s global travel, said co-author Michael Worobey, an evolutionary biologist at the University of Arizona at Tucson. He said studies suggest the virus moved from chimpanzees to humans in the early 20th century, but languished in rural villages for decades before passing into Kinshasa, the capital of Congo. From Kinshasa it may have spread throughout sub-Saharan Africa, and finally moved to the Caribbean, including Haiti, in the mid-1960s.

Note: Watch this astounding 10-minute video where one of the world's leading vaccine experts says that AIDS was imported through "wild viruses" in vaccines. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

In the summer of 2005, Jeffrey Karp, a bioengineer at Brigham and Women’s Hospital [read an] article [detailing] how a group of researchers had created a new synthetic material by mimicking the properties of gecko feet – whose tiny, hair-like pillars allow the lizard to stick to and detach from apparently sheer surfaces with ease. His first thought was to use the material to create a new type of medical tape that could replace sutures and staples, which can damage sensitive tissue surrounding wounds. In 2008, MIT’s Technology Review magazine named Karp one of the top innovators in the world under the age of 35. Karp, who is now 40 and runs his own lab ... is what is known in the business as a bioinspirationalist – a person who looks to nature for solutions to scientific problems. The gecko tape was Karp’s first bioinspired invention. Karp’s current projects include surgical staples inspired by porcupine quills, which create smaller punctures in the skin and prevent bacteria from entering wounds, and a new kind of surgical glue inspired by ... marine worms, which is strong enough to bind moving tissue inside major organs. This last invention has helped to cement Karp’s reputation as a rising star in the world of bioengineering. Because he doesn’t just invent cool stuff – he turns his creations into actual products. “When we look to solve problems, it’s not so we can publish papers,” said Nick Sherman, a research technician at Karp Lab. “It’s more like, ‘Is this work going to help patients?’”

Note: Don't miss pictures and detailed descriptions of some of Karp's nature-inspired inventions at the link above. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Concerns about the inner workings of the U.S. Centers for Disease Control and Prevention (CDC) have been mounting in recent months amid disclosures of cozy corporate alliances. Now a group of more than a dozen senior scientists have reportedly lodged an ethics complaint alleging the federal agency is being influenced by corporate and political interests in ways that short-change taxpayers. A group calling itself CDC Scientists Preserving Integrity, Diligence and Ethics in Research, or CDC SPIDER, put a list of complaints in writing in a letter to the CDC Chief of Staff and provided a copy of the letter to [a] public watchdog organization. The members of the group have elected to file the complaint anonymously for fear of retribution. “It appears that our mission is being influenced and shaped by outside parties and rogue interests... and Congressional intent for our agency is being circumvented by some of our leaders. What concerns us most, is that it is becoming the norm and not the rare exception,” the letter states. The complaint cites among other things a “cover up” of the poor performance of a women’s health program called ... WISEWOMAN. The complaint alleges there was a coordinated effort within the CDC to misrepresent data given to Congress. “Definitions were changed and data ‘cooked’ to make the results look better than they were,” the complaint states. And the complaint cites as “troubling” the ties between soft drink giant Coca-Cola Co. ... and two high-ranking CDC officials.

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and health.

The world cannot rely solely on free markets to deliver medicines needed by billions of people in poor countries, so governments should commit to a legally binding convention to coordinate and fund research and development. That's the conclusion of a major United Nations report. The high-level panel was set up last year by UN Secretary-General Ban Ki-moon to find solutions to the "policy incoherence" between the rights of inventors, international human rights law, trade rules and public health needs. The final report ... calls for a de-linkage of R&D costs and drug prices — at least in areas where the system is failing, such as tropical diseases and the hunt for new antibiotics against "superbug" resistant bacteria. The report attacks the "implicit threats" it says are sometimes used by Western governments and companies to stop poorer countries from exercising their right to over-ride drug patents under World Trade Organization rules. That may not go down well in Washington, given the United States' long-standing defence of the international intellectual property system, which has governed world trade for more than two decades. The panel also calls for greater transparency on the true cost of developing a new drug, citing estimates of anything between $150 million US and $4 billion US per medicine. And it wants disclosure on the real prices paid by insurers and governments for drugs, after discounts. The UN panel consisted of representatives from government, academia, health activism and industry.

Note: Big Pharma has long lobbied for protection of its rights to huge profits from new medicines and kept secret its costs for R&D by refusing to separate these costs from marketing costs. For lots more, read a profoundly revealing essay by the former head of one of the most prestigious medical journals in the world. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and income inequality.

A new study questions the value of mammograms for breast cancer screening. It concludes that a woman is more likely to be diagnosed with a small tumor that is not destined to grow than she is to have a true problem spotted early. The work could further shift the balance of whether screening’s harms outweigh its benefits. Screening is only worthwhile if it finds cancers that would kill, and if treating them early improves survival versus treating when or if they ever cause symptoms. Treatment has improved so much over the years that detecting cancer early has become less important. Mammograms do catch some deadly cancers and save lives. But they also find many early cancers that are not destined to grow or spread and become a health threat. There is no good way to tell which ones will, so many women get treatments they don’t really need. It’s a twin problem: overdiagnosis and overtreatment. Women were considerably more likely to have tumors that were overdiagnosed than to have earlier detection of a tumor that was destined to become large,” the authors write. Dr. Joann Elmore of the University of Washington School of Medicine in Seattle, writes in a commentary in the journal that it’s time to pay more attention to the “collateral damage” of screening - overdiagnosis. “The mantras, ‘All cancers are life-threatening’ and ‘When in doubt, cut it out,’ require revision,” she wrote.

Note: A previous study by The U.S. Preventive Services Task Force, federal advisory panel, found that annual mammograms greatly increase false-positive cancer diagnoses, leading to unnecessary treatment. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

A research report commissioned by Health Canada finds consumers have "strong feelings" about being able to identify genetically modified products when they're shopping, and 78 per cent are calling for clear labelling on packages. "There was a prevailing belief among participants that there should be greater transparency to consumers and, once raised, many questioned why government in particular should be resistant to providing consumers with more information that would help them make more informed decisions," read the findings from The Strategic Counsel. Given the choice, 62 per cent would buy a non-GM food over a GM product out of fears of health hazards or impacts on the environment. According to Health Canada's website, all GM foods are "rigorously assessed" for safety. But labelling is now voluntary. Negative views revealed in the research highlight a "difficult challenge" for Health Canada ahead. Anti-GM advocates have successfully filled the "information void," the report reads. In May, Health Canada provoked controversy when it approved the first genetically modified food animal for sale after "rigorous" scientific reviews. A high number of participants opposed GM food in any form, the report said. Only 26 per cent of respondents indicated they would be comfortable eating foods that have been genetically modified, and just 22 per cent support the development and sale of GM foods in Canada.

Note: For more along these lines, see concise summaries of deeply revealing news articles on GMO controversies and food system corruption.

Using the playbook of Mylan, Turing and, well, their own company, Valeant Pharmaceuticals has hiked the price of yet another life-saving treatment to astronomical values. This time, it’s calcium EDTA, a lead poisoning treatment that cost US hospitals and poison control centers about $500 for a packet of six ampules (6 grams) before 2012, when Valeant acquired the drug. Poison control experts now say that US centers pay about $5000 per gram for the drug, compared to $15 per gram for Canadians. In a 6-year period ... Valeant increased the US price of the drug by as much as 7200%. Two physicians - Michael Kosnett from the University of Colorado School of Medicine and Timur Durrani at the University of California, San Francisco (UCSF) - expressed their concerns about these price hikes in a letter to U.S. Rep. Elijah Cummings (D-Md), the ranking member of the House Committee on Oversight and Government Reform. According to Kosnett and Durrani, the average price per milliliter for the drug went from $18.57 in 2008 to $1346.37 in 2014. U.S. hospitals have no other source for calcium EDTA. Most of those who develop acute lead poisoning are children. The effects of lead poisoning are lasting and profound. Calcium EDTA is on the World Health Organization’s Model List of Essential Medicines, which lists medications that are most critical for a healthcare system to have on hand.

Note: For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.